Mice defective in two apoptosis pathways in the myeloid lineage develop acute myeloblastic leukemia

Immunity

Volumn 9, Issue 1, 1998, Pages 47-57

  Traver, David ^a   Akashi, Koichi ^a   Weissman, Irving L ^a   Lagasse, Eric ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE MYELOBLASTIC LEUKEMIA; ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL TRANSFORMATION; HEMATOPOIETIC CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTE;

EID: 0032126364     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80587-7     Document Type: Article

References (52)

1. Aguila, H.L., and Weissman, I.L (1996). Hematopoietic stem cells are not direct cytotoxic targets of natural killer cells. Blood 87, 1225-1231.
2. Akashi, K., Harada, M., Shibuya, T., Eto, T., Takamatsu, Y., Teshima, T., and Niho, Y. (1991). Effects of interleukin-4 and interleukin-6 on the proliferation of CD34+ and CD34-blasts from acute myelogenous leukemia. Blood 78, 197-204.
3. Alderson, M.R., Tough, T.W., Davis-Smith, T., Braddy, S., Falk, B., Schooley, K.A., Goodwin, R.G., Smith, C.A., Ramsdell, F., and Lynch, D.H. (1995). Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181, 71-77.
4. Bakhshi, A., Jensen, J.P., Goldman, P., Wright, J.J., McBride, O.W., Epstein, A.L., and Korsmeyer, S.J. (1985). Cloning thechromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transitional unit on 18. Cell 14, 899-906.
5. Becker, A.J., McCulloch, E.A., and Till, J.E. (1963). Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature 197, 452-454.
6. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H.R., and Sultan, C. (1976). Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br. J. Haematol. 33, 451-458.
7. Bensi, L., Longo, R., Vecchi, A., Messora, C., Garagnani, L., Bernardi, S., Tamassia, M.G., and Sacchi, S. (1995). Bcl-2 oncoprotein expression in acute myeloid leukemia. Haematologica 80, 98-102.
8. Bouscary, D., De Vos, J., Guesnu, M., Jondeau, K., Viguier, F., Melle, J., Picard, F., Dreyfus, F., and Fontenay-Roupie, M. (1997). Fas/ Apo-1 (CD95) expression and apoptosis in patients with myelodys-plastic syndromes. Leukemia 11, 839-845.
9. Cleary, M.L., and Sklar, J. (1985). Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc. Natl. Acad. Sci. USA 82, 7439-7443.
10. Collins, S.J. (1987). The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood 70, 1233-1244.
11. Cory, S., Harris, A.W., and Strasser, A. (1994). Insights from transgenic mice regarding the role of bcl-2 in normal and neoplastic lymphoid cells. Philos. Trans. R. Soc. Lond. B Biol. Sci. 345, 289-295.
12. Daniel, P.T., and Krammer, P.H. (1994). Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells. J. Immunol. 152, 5624-5632.
13. Delia, D., Aiello, A., Soligo, D., Fontanella, E., Melani, C., Pezzella, F., Pierotti, M.A., and Della Porta, G. (1992). bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells. Blood 79, 1291-1298.
14. Dirks, W., Schone, S., Uphoff, C., Quentmeier, H., Pradella, S., and Drexler, H.G. (1997). Expression and function of CD95 (FAS/APO-1) in leukaemia-lymphoma tumour lines. Br. J. Haematol. 96, 584-593.
15. Erickson, P., Gao, J., Chang, K.S., Look, T., Whisenant, E., Raimondi, S., Lasher, R., Trujillo, J., Rowley, J., and Drabkin, H. (1992). Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood 80, 1825-1831.
16. Fleming, W.H., Alpern, E.J., Uchida, N., Ikuta, K., Spangrude, G.J., and Weissman, I.L (1993). Functional heterogeneity is associated with the cell cycle status of murine hematopoietic stem cells. J. Cell Biol. 122, 897-902.
17. Itoh, N., Tsujimoto, Y., and Nagata, S. (1993). Effect of bcl-2 on Fas antigen-mediated cell death. J. Immunol. 151, 621-627.
18. Kagi, D., Vignaux, F., Ledermann, B., Burki, K., Depraetere, V., Nagata, S., Hengartner, H., and Golstein, P. (1994). Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265, 528-530.
19. Klampfer, L., Zhang, J., Zelenetz, A.O., Uchida, H., and Nimer, S.D. (1996). The AML1/ETO fusion protein activates transcription of BCL-2. Proc. Natl. Acad. Sci. USA 93, 14059-14064.
20. Komada, Y., Zhou, Y.W., Zhang, X.L., Xue, H.L., Sakai, H., Tanaka, S., Sakatoku, H., and Sakurai, M. (1995). Fas receptor (CD95)-mediated apoptosis is induced in leukemic cells entering G1B compartment of the cell cycle. Blood 86, 3848-3860.
21. Lagasse, E., and Weissman, I.L. (1994). Bcl-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages. J. Exp. Med. 179, 1047-1052.
22. Lagasse, E., and Weissman, I.L. (1997). Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell 89, 1021-1031.
23. Liles, W.C., Kiener, P.A., Ledbetter, J.A., Aruffo, A., and Klebanoff, S.J. (1996). Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J. Exp. Med. 184, 429-440.
24. Lowin, B., Hahne, M., Mattmann, C., and Tschopp, J. (1994). Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370, 650-652.
25. Marshall, C.J. (1991). Tumor suppressor genes. Cell 64, 313-326.
26. Metcalf, D. (1989). The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature 339, 27-30.
27. Min, Y.H., Lee, S., Lee, J.W., Chong, S.Y., Hahn, J.S., and Ko, Y.W. (1996). Expression of Fas antigen in acute myeloid leukaemia is associated with therapeutic response to chemotherapy. Br. J. Haematol. 93, 928-930.
28. Miyamoto, T., Nagafuji, K., Akashi, K., Harada, M., Kyo, T., Akashi, T., Takenaka, K., Mizuno, S., Gondo, H., and Okamura, T. (1996). Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia. Blood 87, 4789-8796.
29. Miyoshi, H., Shimizu, K., Kozu, T., Maseki, N., Kaneko, Y., and Ohki, M. (1991). t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc. Natl. Acad. Sci. USA 88, 10431-10434.
30. Morrison, S.J., and Weissman, I.L. (1994). The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity 1, 661-673.
31. Nagata, S. (1997). Apoptosis by death factor. Cell 88, 355-365.
32. Nucifora, G., Larson, R.A., and Rowley, J.D. (1993). Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. Blood 82, 712-715.
33. Okuda, T., van Deursen, J., Hiebert, S.W., Grosveld, G., and Downing, J.R. (1996). AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84, 321-330.
34. Peng, S.L., Robert, M.E., Hayday, A.C., and Craft, J. (1996). A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice. J. Exp. Med. 184, 1149-1154.
35. Rabbitts, T.H. (1991 ). Translocations, master genes, and differences between the origins of acute and chronic leukemias. Cell 67, 641-644.
36. Rabbitts, T.H. (1994). Chromosomal translocations in human cancer. Nature 372, 143-149.
37. Robertson, M.J., Manley, T.J., Pichert, G., Cameron, C., Cochran, K.J., Levine, H., and Ritz, J. (1995). Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells. Leuk. Lymphoma 17, 51-61.
38. Russell, J.H., Rush, B., Weaver, C., and Wang, R. (1993). Mature T cells of autoimmune Ipr/Ipr mice have a defect in antigen-stimulated suicide. Proc. Natl. Acad. Sci. USA 90, 4409-4413.
39. Sawyers, C.L., Denny, C.T., and Witte, O.N. (1991). Leukemia and the disruption of normal hematopoiesis. Cell 64, 337-350.
40. Schiffer, C.A. (1997). Acute myeloid leukemia in adults. In Cancer Medicine, J.F. Holland, R.C Bast, D.L. Morton, E. Frei, D.W. Kufe, and R.R. Weichselbaum, eds. (Baltimore, MD: Williams and Wilkins), pp. 2617-2649.
41. Singer, G., and Abbas, A. (1994). The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1, 365-371.
42. Spangrude, G.J., Heimfeld, S., and Weissman, I.L. (1988). Purification and characterization of mouse hematopoietic stem cells Science 241, 58-62.
43. Strasser, A., Harris, A.W., Huang, D.C., Krammer, P.H., and Cory, S. (1995). Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14, 6136-6147.
44. Suda, T., and Nagata, S. (1994). Purification and characterization of the Fas-ligand that induces apoptosis. J. Exp. Med. 179, 873-879.
45. Tenen, D.G., Hromas, R., Licht, J.D., and Zhang, D.E. (1997). Transcription factors, normal myeloid development, and leukemia. Blood 90, 489-519.
46. Till, J.E., and McCulloch, E.A. (1961). A direct measure of the radiation sensitivity of normal mouse bone marrow cells. Radiat. Res. 213-222.
47. Vaux, D.L., Cory, S., and Adams, J.M. (1988). Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335, 440-442.
48. Wang, Q., Stacy, T., Binder, M., Marin-Padilla, M., Sharpe, A.H., and Speck, N.A. (1996). Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl. Acad. Sci. USA 93, 3444-3449.
49. Weinberg, R.A. (1991). Tumor suppressor genes. Science 254, 1138-1146.
50. Wu, A.M., Till, J.E., Siminovitch, L., and McCulloch, E.A. (1967). A cytological study of the capacity for differentiation of normal hemopoietic colony-forming cells. J. Cell. Physiol. 69, 177-184.
51. Yang, E., and Korsmeyer, S.J. (1996). Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 88, 386-401.
52. Yergeau, D.A., Hetherington, C.J., Wang, Q., Zhang, P., Sharpe, A.H., Binder, M., Marin-Padilla, M., Tenen, D.G., Speck, N.A., and Zhang, D.E. (1997). Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene. Nat. Genet. 15, 303-306.